Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLCByoung Chul Cho, Patricia Lorenzini, Adlinda Alip et al.|New England Journal of Medicine|2024Cited by 369
MicroRNA-214-3p inhibits the stem-like properties of lung squamous cell cancer by targeting YAP1Tingting Lü, Shun Lu|Cancer Cell International|2020Cited by 31
MicroRNA-214-3p Inhibits the Stem-Like Properties of Lung Squamous Cell Cancer by Targeting YAP1Tingting Lu, Shun Lu|Research Square|2020Cited by 0
MicroRNA-214-3p Inhibits the Stem-Like Properties of Lung Squamous Cell Cancer by Targeting YAP1Tingting Lü, Shun Lu|Research Square|2020Cited by 0
MicroRNA-214-3p Inhibits the Stem-Like Properties of Lung Squamous Cell Cancer by Targeting YAP1Tingting Lü, Shun Lu|Research Square|2020Cited by 0